COMMUNIQUÉS West-GlobeNewswire

Silo Pharma Announces up to $11.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules
10/07/2026
$4 million upfront with up to approximately $7.7 million of potential additional gross proceeds upon the exercise in full of warrants in cash SARASOTA, FLA., July 10, 2026 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: [...]
Communiqué de presse : Sarclisa Escena de Sanofi, la formulation sous-cutanée du Sarclisa, approuvé aux États-Unis comme premier traitement anticancéreux administré via un injecteur portable
10/07/2026
Sarclisa Escena de Sanofi, la formulation sous-cutanée du Sarclisa, approuvé aux États-Unis comme premier traitement anticancéreux administré via un injecteur portable Sarclisa Escena administrée à l’aide de l’injecteur [...]
Dubai Health and Rush University System for Health Announce Strategic Collaboration to Advance Quality of Care
10/07/2026
Dubai, United Arab Emirates, July 10, 2026 (GLOBE NEWSWIRE) -- Dubai Health has announced a strategic collaboration with Rush University System for Health, one of the leading United States-based academic healthcare [...]
BioStem Technologies Publicly Files Form 10 Registration Statement with the Securities and Exchange Commission
10/07/2026
Advances progress towards planned Nasdaq uplisting POMPANO BEACH, Fla., July 10, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM) (“BioStem” or the “Company”), a leading regenerative medicine company [...]
SL Science Holding Limited Submits Orphan Drug Designation Request to the U.S. FDA for GDT Cell Therapy Targeting Glioblastoma
10/07/2026
Taipei, TAIWAN, July 10, 2026 (GLOBE NEWSWIRE) -- SL Science Holding Limited (“SL Science” or the “Company”) (Nasdaq: SLBT), a Taiwan-headquartered biomedical company specializing in developing innovative cellular and [...]
Frishantic Launches Vitamin D3 K2 5000 IU Supplement for Indoor-Heavy Lifestyles
10/07/2026
A one-daily softgel formula designed to support bone health, normal immune function, and daily wellness for adults navigating modern indoor routines. NEW YORK, July 10, 2026 (GLOBE NEWSWIRE) -- Frishantic , a wellness [...]
SRX Global Management Team to Host Virtual Fireside Chat on July 14, 2026, and Issues Letter to Shareholders
10/07/2026
Virtual Fireside Chat Scheduled for Tuesday, July 14, 2026, at 10:30 a.m. ET NORTH PALM BEACH, Fla., July 10, 2026 (GLOBE NEWSWIRE) -- SRX Global, Inc. (NYSE American: SRXH) (the "Company", or “SRX”), an AI-enabled [...]
Palisade Bio to Participate in the Leerink Partners Therapeutics Forum
10/07/2026
Management to participate in investor meetings on July 14-15 in Boston Denver, CO, July 10, 2026 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), a clinical-stage biopharmaceutical [...]
Authority Magazine Features Kraig Biocraft Laboratories CEO Kim Thompson as an Industry Disruptor Reshaping the Future of Advanced Materials
10/07/2026
Interview Highlights Thompson's Entrepreneurial Vision and Kraig Labs' Mission to Bring Spider Silk to Commercial Scale ANN ARBOR, Mich., July 10, 2026 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB [...]
Press Release: Sanofi’s subcutaneous Sarclisa Escena approved in the US as first anticancer treatment administered via on-body injector
10/07/2026
Sanofi’s subcutaneous Sarclisa Escena approved in the US as first anticancer treatment administered via on-body injector Sarclisa Escena administered via the CirCLIQ ® on-body injector (OBI) offers a treatment [...]
VYNE Therapeutics Declares Special Cash Dividend in Connection with the Proposed Merger with Yarrow Bioscience
10/07/2026
Aggregate cash dividend of an estimated $16.5 million, or an estimated $0.38 per share NEW YORK, July 10, 2026 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced that its [...]
PatchMD Adds a Topical Berberine Patch to Its Lineup
10/07/2026
The Las Vegas company that introduced the first vitamin patch in 2009 expands its metabolic line with a plant-based patch that delivers berberine and five supporting extracts through the skin. LAS VEGAS, NV, July 10, [...]
Grifols deaths and harm: Patient safety & options for accountability
10/07/2026
TORONTO, July 10, 2026 (GLOBE NEWSWIRE) -- Will Trial Lawyers and the Ontario Health Coalition invite members of the media to attend a press conference regarding patient safety issues related to Grifols, one of the [...]
Study Results of Orelabrutinib in Patients with SLE Published in the Journal of Autoimmunity
10/07/2026
BEIJING, July 10, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), today announced that the Journal of Autoimmunity has published results from a clinical study evaluating orelabrutinib, a BTK (Bruton [...]
Clearmind Medicine Responds to the U.S. Administration’s RFI for Addiction Treatment Innovations as Part of the Great American Recovery Initiative
10/07/2026
Vancouver, Canada, July 10, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), a clinical-stage a biotech company developing novel, non-hallucinogenic, next-generation, neuroplastogen-derived therapeutics [...]
BiomX: Zorronet Completes Transition to New Advanced Data Center Supporting Business Expansion and Enhanced AI Capabilities
10/07/2026
NETANYA, Israel, July 10, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a company focused on defense, security, and critical infrastructure technologies, today announced that its [...]
Alamar Biosciences NULISA Data Featured in More Than 140 Scientific Presentations at AAIC 2026, Highlighting Advances in Blood-Based Alzheimer’s Biomarker Profiling
10/07/2026
Company to host scientific workshop featuring emerging eMTBR-Tau and BD-pTau217 research data for Alzheimer’s disease detection and staging FREMONT, Calif., July 10, 2026 (GLOBE NEWSWIRE) -- Alamar Biosciences, Inc. ( [...]
BMGL Regains Compliance With Nasdaq Minimum Bid Price Requirement
10/07/2026
Singapore, July 10, 2026 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (Nasdaq: BMGL) (the “Company”) today announced that it has received notification from Nasdaq that the Company has regained compliance with the Nasdaq [...]
No easy answers: European research consortia take on major challenges
10/07/2026
COPENHAGEN, Denmark, July 10, 2026 (GLOBE NEWSWIRE) -- Nine new Challenge Programme grants from the Novo Nordisk Foundation will support ambitious research across fungal diseases, cardiometabolic disease, soil health [...]

Pages